SIMULATOR FOR CATHETER-BASED CARDIOVASCULAR PROCEDURES

基于导管的心血管手术模拟器

• 批准号: 6140523
• 负责人: JOSEPH L TASTO
• 金额: $ 9.99万
• 依托单位: IMMERSION MEDICAL, INC.
• 依托单位国家: 美国
• 财政年份: 2000
• 资助国家: 美国
• 起止时间: 2000-07-01 至 2000-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6140523
• 关键词: blood vessel prosthesis; cardiovascular surgery; catheterization; computer human interaction; computer program /software; computer simulation; computer system design /evaluation; continuing education; educational resource design /development; human data; interactive multimedia; medical education

Less invasive cardiovascular interventional techniques, such as transcatheter placement of endovascular grafts, are increasingly being developed. A large challenge to the adoption of these new procedures is physician training. HT Medical proposes research that will provide an opportunity for training without risk to patients. The goal of this project is to improve clinical outcomes through the development of a "virtual reality" simulator for endovascular placement of stents, stent grafts, and angioplasty. For Phase I, feasibility will be demonstrated by developing a prototype that focuses on endovascular placement of stent grafts for abdominal aortic aneurysm repairs. The prototype will be evaluated by a panel of physicians who perform this procedure. In Phase II, the visual and tactile enhancements that are necessary for commercialization will be made based on input from this physician panel. The prototype will be advanced to allow the user to perform other endovascular interventions, such as coronary artery stenting. A comprehensive study will be conducted to evaluate the simulator's training efficacy. During Phase III, medical schools, physician training programs, medical device companies, and CME organizations will be targeted. The market base will be expanded by building other medical simulators, using technology developed for this simulator. PROPOSED COMMERCIAL APPLICATIONS: Endovascular therapies are one of the fastest growing areas in procedural medicine. The proposed technology will facilitate that growth. The target market includes medical schools, physician training programs, medical device companies, and organizations and hospitals that teach Continuing Medical Education courses. We plan on capturing an even larger market by leveraging the technology developed for this simulator to produce other medical simulators.

越来越多地开发出较少的浸润性心血管介入技术，例如内血管移植的经经导管的放置。 对采用这些新程序的挑战是医师培训。 HT Medical提出的研究将为培训提供机会，而不会为患者带来风险。 该项目的目的是通过开发“虚拟现实”模拟器来改善临床结果，用于血管内的支架，支架移植物和血管成形术。对于第一阶段，将通过开发专注于腹主动脉瘤修复的支架移植物的原型来证明可行性。该原型将由执行此程序的医师小组评估。在第二阶段中，将根据该医师小组的意见进行商业化所需的视觉和触觉增强功能。 该原型将允许用户执行其他血管内干预措施，例如冠状动脉支架。将进行一项全面的研究，以评估模拟器的训练功效。在第三阶段，医学院，医师培训计划，医疗设备公司和CME组织将成为针对目标。使用该模拟器开发的技术，将通过构建其他医疗模拟器来扩展市场群。拟议的商业应用：血管内疗法是程序医学中生长最快的地区之一。拟议的技术将促进这种增长。 目标市场包括医学院，医师培训计划，医疗设备公司以及教授继续医学教育课程的组织和医院。我们计划通过利用为该模拟器开发的技术来生产其他医疗模拟器来捕获更大的市场。